Press Center

Press Releases




TrendForce Expects Sluggish Growth for Hepatitis B Drug Market with 2015~2023 CAGR at 0.4%

29 August 2016

The scale of the global hepatitis B drug market was around US$2.15 billion in 2015 and is forecast to grow slowly at a CAGR of just 0.4% to US$2.2 billion in 2023, according to the latest biotechnology report from the global market research firm TrendForce.

TrendForce Says Worldwide Success of Pokémon GO Will Help Global AR Software Market Reach US$30 Billion in Scale by 2020

21 July 2016

With download and active user numbers far exceeding other popular apps, Nintendo’s Pokémon GO has generated an enormous wave of enthusiasm for mobile gaming and augmented reality (AR) technology worldwide. According to the latest analysis from the global market research firm TrendForce, the revenue from Pokémon GO is forecast to top US$800 million in 2017. The game is set to become a significant contributor to the expansion of the global AR software market, which will reach US$30 billion in scale by 2020.

Positive Outlook for Global Generic Drug Market as Countries Worldwide Promotes Generics to Help Control Healthcare Costs, Says TrendForce

23 June 2016

Aging population and rising costs of new drugs have increased healthcare expenses in countries across the globe and spurred governments to expand the use of generic drugs. Currently, there are factors constraining the development of generics. The U.S., for instance, is pushing the international adoption of patent linkage via the Trans-Pacific Partnership (TPP) and Bilateral Free Trade Agreements (BFTAs).

Chinese Government’s 13th Five-Year Plan Will Drive High-Speed Growth in the Country’s Robotics Industry in Next Five Years, Says TrendForce

26 May 2016

China will continue to bolster the development of a domestic robotics industry, according to a new robotics technology roadmap that was recently released by the Chinese government for the 13th Five-Year Plan period (2016~2020). China aims to have three to five internationally competitive domestic robotics companies by 2020.

Japan’s Rising Demand for Protein Drug Manufacturing and Regenerative Medicine Boom Capture Attention of Major Biotech Companies, Says TrendForce

20 May 2016

Japan has enormous influence over the development of the global biotech industry. The country is the world’s third-largest pharmaceutical and biotech market after the U.S. and China. It is also ranked second globally in terms of R&D spending in pharmaceutical and biotech industry. One of the major trade exhibitions in Japan, Life Science World 2016, was held in Tokyo earlier this May.


  • Page 23
  • 30 page(s)
  • 149 result(s)

Get in touch with us